(KR) Kroger - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5010441013
Stock: Groceries, Pharmacy, Fuel, Apparel, General Merchandise
Total Rating 55
Risk 73
Buy Signal 0.54
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | -7.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 19.80 |
| Character TTM | |
|---|---|
| Beta | -0.235 |
| Beta Downside | 0.047 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.44% |
| CAGR/Max DD | 0.98 |
EPS (Earnings per Share)
Revenue
Description: KR Kroger March 02, 2026
The Kroger Co. (NYSE: KR) is a U.S. food and drug retailer that runs a diversified portfolio of formats-including combination food-and-drug stores, multi-department stores, marketplace stores, and price-impact warehouses-along with its own food-manufacturing, fuel centers, and online sales channels.
In its most recent fiscal year (FY 2025), Kroger reported revenue of $136.2 billion, with comparable-store sales rising 3.1% year-over-year and digital sales now representing roughly 13% of total sales; its operating margin improved to 3.2% and its private-label share reached a record 31% of basket value.
Key drivers for the grocery sector remain consumer price sensitivity as inflation eases, a continued shift toward higher-margin private-label and organic products, and accelerated e-commerce adoption-areas where Kroger’s robust omnichannel platform and extensive fresh-food assortment give it a competitive edge.
For deeper quantitative analysis, you may want to explore ValueRay’s detailed model on KR.
Headlines to watch out for
- Grocery price inflation impacts consumer spending
- Labor costs and supply chain efficiency affect margins
- Online grocery sales growth drives market share
- Regulatory scrutiny on mergers and acquisitions
- Fuel price volatility influences consumer traffic
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 789.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.86 > 1.0 |
| NWC/Revenue: -1.51% < 20% (prev 5.84%; Δ -7.35% < -1%) |
| CFO/TA 0.12 > 3% & CFO 6.04b > Net Income 789.0m |
| Net Debt (21.24b) to EBITDA (5.29b): 4.01 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (655.0m) vs 12m ago -10.03% < -2% |
| Gross Margin: 22.70% > 18% (prev 0.23%; Δ 2247 % > 0.5%) |
| Asset Turnover: 258.6% > 50% (prev 240.1%; Δ 18.49% > 0%) |
| Interest Coverage Ratio: 2.05 > 6 (EBITDA TTM 5.29b / Interest Expense TTM 714.0m) |
Altman Z'' 2.37
| A: -0.04 (Total Current Assets 15.99b - Total Current Liabilities 18.22b) / Total Assets 51.44b |
| B: 0.55 (Retained Earnings 28.20b / Total Assets 51.44b) |
| C: 0.03 (EBIT TTM 1.47b / Avg Total Assets 56.93b) |
| D: 0.66 (Book Value of Equity 29.51b / Total Liabilities 44.40b) |
| Altman-Z'' Score: 2.37 = BBB |
Beneish M -2.98
| DSRI: 1.10 (Receivables 2.37b/2.19b, Revenue 147.22b/149.88b) |
| GMI: 1.00 (GM 22.70% / 22.62%) |
| AQI: 1.14 (AQ_t 0.09 / AQ_t-1 0.08) |
| SGI: 0.98 (Revenue 147.22b / 149.88b) |
| TATA: -0.10 (NI 789.0m - CFO 6.04b) / TA 51.44b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of KR shares?
As of March 09, 2026, the stock is trading at USD 74.11 with a total of 10,636,223 shares traded.
Over the past week, the price has changed by +7.33%, over one month by +6.25%, over three months by +17.52% and over the past year by +11.67%.
Over the past week, the price has changed by +7.33%, over one month by +6.25%, over three months by +17.52% and over the past year by +11.67%.
Is KR a buy, sell or hold?
Kroger has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold KR.
- StrongBuy: 9
- Buy: 3
- Hold: 12
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.4 | -1% |
| Analysts Target Price | 73.4 | -1% |
KR Fundamental Data Overview March 07, 2026
P/E Trailing = 63.3363
P/E Forward = 12.8205
P/S = 0.3221
P/B = 6.1101
P/EG = 1.5837
Revenue TTM = 147.22b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 5.29b USD
Long Term Debt = 14.55b USD (from longTermDebt, last quarter)
Short Term Debt = 2.60b USD (from shortTermDebt, last quarter)
Debt = 25.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.24b USD (from netDebt column, last quarter)
Enterprise Value = 68.67b USD (47.43b + Debt 25.20b - CCE 3.96b)
Interest Coverage Ratio = 2.05 (Ebit TTM 1.47b / Interest Expense TTM 714.0m)
EV/FCF = 30.55x (Enterprise Value 68.67b / FCF TTM 2.25b)
FCF Yield = 3.27% (FCF TTM 2.25b / Enterprise Value 68.67b)
FCF Margin = 1.53% (FCF TTM 2.25b / Revenue TTM 147.22b)
Net Margin = 0.54% (Net Income TTM 789.0m / Revenue TTM 147.22b)
Gross Margin = 22.70% ((Revenue TTM 147.22b - Cost of Revenue TTM 113.81b) / Revenue TTM)
Gross Margin QoQ = 21.03% (prev 23.01%)
Tobins Q-Ratio = 1.33 (Enterprise Value 68.67b / Total Assets 51.44b)
Interest Expense / Debt = 0.58% (Interest Expense 146.0m / Debt 25.20b)
Taxrate = 20.05% (670.0m / 3.34b)
NOPAT = 1.17b (EBIT 1.47b * (1 - 20.05%))
Current Ratio = 0.88 (Total Current Assets 15.99b / Total Current Liabilities 18.22b)
Debt / Equity = 3.58 (Debt 25.20b / totalStockholderEquity, last quarter 7.04b)
Debt / EBITDA = 4.01 (Net Debt 21.24b / EBITDA 5.29b)
Debt / FCF = 9.45 (Net Debt 21.24b / FCF TTM 2.25b)
Total Stockholder Equity = 8.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 789.0m / Total Assets 51.44b)
RoE = 9.41% (Net Income TTM 789.0m / Total Stockholder Equity 8.38b)
RoCE = 6.39% (EBIT 1.47b / Capital Employed (Equity 8.38b + L.T.Debt 14.55b))
RoIC = 4.72% (NOPAT 1.17b / Invested Capital 24.82b)
WACC = 3.46% (E(47.43b)/V(72.63b) * Re(5.05%) + D(25.20b)/V(72.63b) * Rd(0.58%) * (1-Tc(0.20)))
Discount Rate = 5.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.95%
[DCF] Terminal Value 86.31% ; FCFF base≈2.23b ; Y1≈2.22b ; Y5≈2.34b
[DCF] Fair Price = 76.55 (EV 69.68b - Net Debt 21.24b = Equity 48.44b / Shares 632.8m; r=5.90% [WACC]; 5y FCF grow -0.92% → 2.90% )
EPS Correlation: 13.47 | EPS CAGR: -3.27% | SUE: 1.20 | # QB: 2
Revenue Correlation: -5.43 | Revenue CAGR: 0.65% | SUE: -0.89 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.68 | Chg7d=-0.005 | Chg30d=-0.009 | Revisions Net=-1 | Analysts=14
EPS current Year (2027-01-31): EPS=5.27 | Chg7d=-0.009 | Chg30d=-0.027 | Revisions Net=-3 | Growth EPS=+8.7% | Growth Revenue=+2.0%
EPS next Year (2028-01-31): EPS=5.58 | Chg7d=-0.005 | Chg30d=-0.025 | Revisions Net=-2 | Growth EPS=+5.8% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.4% (Discount Rate 7.9% - Earnings Yield 1.6%)
[Growth] Growth Spread = -5.2% (Analyst 1.2% - Implied 6.4%)
P/E Forward = 12.8205
P/S = 0.3221
P/B = 6.1101
P/EG = 1.5837
Revenue TTM = 147.22b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 5.29b USD
Long Term Debt = 14.55b USD (from longTermDebt, last quarter)
Short Term Debt = 2.60b USD (from shortTermDebt, last quarter)
Debt = 25.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.24b USD (from netDebt column, last quarter)
Enterprise Value = 68.67b USD (47.43b + Debt 25.20b - CCE 3.96b)
Interest Coverage Ratio = 2.05 (Ebit TTM 1.47b / Interest Expense TTM 714.0m)
EV/FCF = 30.55x (Enterprise Value 68.67b / FCF TTM 2.25b)
FCF Yield = 3.27% (FCF TTM 2.25b / Enterprise Value 68.67b)
FCF Margin = 1.53% (FCF TTM 2.25b / Revenue TTM 147.22b)
Net Margin = 0.54% (Net Income TTM 789.0m / Revenue TTM 147.22b)
Gross Margin = 22.70% ((Revenue TTM 147.22b - Cost of Revenue TTM 113.81b) / Revenue TTM)
Gross Margin QoQ = 21.03% (prev 23.01%)
Tobins Q-Ratio = 1.33 (Enterprise Value 68.67b / Total Assets 51.44b)
Interest Expense / Debt = 0.58% (Interest Expense 146.0m / Debt 25.20b)
Taxrate = 20.05% (670.0m / 3.34b)
NOPAT = 1.17b (EBIT 1.47b * (1 - 20.05%))
Current Ratio = 0.88 (Total Current Assets 15.99b / Total Current Liabilities 18.22b)
Debt / Equity = 3.58 (Debt 25.20b / totalStockholderEquity, last quarter 7.04b)
Debt / EBITDA = 4.01 (Net Debt 21.24b / EBITDA 5.29b)
Debt / FCF = 9.45 (Net Debt 21.24b / FCF TTM 2.25b)
Total Stockholder Equity = 8.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 789.0m / Total Assets 51.44b)
RoE = 9.41% (Net Income TTM 789.0m / Total Stockholder Equity 8.38b)
RoCE = 6.39% (EBIT 1.47b / Capital Employed (Equity 8.38b + L.T.Debt 14.55b))
RoIC = 4.72% (NOPAT 1.17b / Invested Capital 24.82b)
WACC = 3.46% (E(47.43b)/V(72.63b) * Re(5.05%) + D(25.20b)/V(72.63b) * Rd(0.58%) * (1-Tc(0.20)))
Discount Rate = 5.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.95%
[DCF] Terminal Value 86.31% ; FCFF base≈2.23b ; Y1≈2.22b ; Y5≈2.34b
[DCF] Fair Price = 76.55 (EV 69.68b - Net Debt 21.24b = Equity 48.44b / Shares 632.8m; r=5.90% [WACC]; 5y FCF grow -0.92% → 2.90% )
EPS Correlation: 13.47 | EPS CAGR: -3.27% | SUE: 1.20 | # QB: 2
Revenue Correlation: -5.43 | Revenue CAGR: 0.65% | SUE: -0.89 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.68 | Chg7d=-0.005 | Chg30d=-0.009 | Revisions Net=-1 | Analysts=14
EPS current Year (2027-01-31): EPS=5.27 | Chg7d=-0.009 | Chg30d=-0.027 | Revisions Net=-3 | Growth EPS=+8.7% | Growth Revenue=+2.0%
EPS next Year (2028-01-31): EPS=5.58 | Chg7d=-0.005 | Chg30d=-0.025 | Revisions Net=-2 | Growth EPS=+5.8% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.4% (Discount Rate 7.9% - Earnings Yield 1.6%)
[Growth] Growth Spread = -5.2% (Analyst 1.2% - Implied 6.4%)